The U.S. PRP and stem cell alopecia treatment market size is expected to reach USD 183.3 million by 2025 at a 5.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing a positive patient outcome. Moreover, lower incidence of negative side effects due to this therapy is anticipated to fuel demand for platelet-rich plasma (PRP) and stem cell therapy.
Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to a rise in the number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.
For PDF sample Copy or More Details please visit link @: https://www.grandviewresearch.com/industry-analysis/us-platelet-rich-plasma-prp-stem-cell-alopecia-treatment-market
By treatment type, PRP procedures accounted for the largest share of 58.1% in 2017 in terms of procedural volume. However, owing to lower prices of PRP procedures, stem cell therapy procedures accounted for the dominant revenue share in 2017, valued at USD 70.1 million. By end use, the dermatology clinics segment accounted for 85.0% of the total market revenue in 2017, owing to its lower therapy cost as compared to hospitals.
The competitive landscape includes clinics such as Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, PLC, NovaGenix, Virginia Surgical Center, and Hair Transplant Institute of Miami.
Further key findings from the report suggest:
• PRP procedures dominated the market in terms of volume in 2017, owing to its safety, effectiveness, and minimal chances of failure
• Stem cell therapy accounted for the dominant revenue share in 2017 owing to higher prices of PRP procedures as compared to stem cell therapy. The segment was valued at USD 70.1 million in 2017
• The dermatology clinic segment held the largest revenue share in 2017, accounting for USD 105.2 million
• Some of the clinics providing PRP and stem cell therapy for alopecia in this market are the Hair Sciences Center of Colorado, Anderson Center, PLC, Nova Genix, and Hair Transplant Institute of Miami.
To request research report sample copy with TOC please visit @: https://www.grandviewresearch.com/industry-analysis/us-platelet-rich-plasma-prp-stem-cell-alopecia-treatment-market/request/rs1
Grand View Research has segmented the U.S. PRP and stem cell alopecia treatment market on the basis of treatment and end user:
U.S. PRP and Stem Cell Alopecia Treatment Outlook (Procedures; Revenue, USD Million, 2013 - 2025)
• Platelet Rich Plasma (PRP) Injections
• Stem Cell Therapy
U.S. PRP and Stem Cell Alopecia Treatment End User (Procedures; Revenue, USD Million, 2013 - 2025)
• Hospital
• Dermatology Clinics
• Others
For Inquire before buying please visit @: https://www.grandviewresearch.com/inquiry/5418/ibb
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.